Eli Lilly and Company
Pagina dedicata companiei Eli Lilly and Company listata cu simbolul US.LLY
Descriere companie[edit | ]
Eli Lilly and Company (www.lilly.com) is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Grafic actiuni companie[edit | ]
Ultimele stiri despre Eli Lilly and Company (US.LLY)[edit | ]
- Deficitul comercial se reduce usor - 10 februarie 2026
- Romania, cel mai mare importator de seminte de floarea-soarelui - 05 februarie 2026
- Comertul cu ridicata revine usor - 30 ianuarie 2026
- Lucrarile de constructii accelereaza - 19 decembrie 2025
- BVB, inchisa pe 24 si 31 decembrie - 09 decembrie 2025
- Infrastructura de irigatii a Romaniei - 24 noiembrie 2025
- Start pentru Fidelis in noiembrie - 07 noiembrie 2025
- Scad inmatricularile de autoturisme noi - 26 septembrie 2025
- Criza acuta de forta de munca - 27 august 2025
- Industria, in scadere substantiala - 08 august 2025